An in-depth understanding of clinical oncology and cellular cancer biology

A portfolio of novel multifunctional drugs that simultaneously target compensatory mechanisms pertinent to carcinogenesis and resistance to chemotherapy

A strong IP position covering the major pharmaceutical markets worldwide

A top-level management team and scientific and clinical advisory board with extensive experience, expertise, and credibility in biopharmaceutical industry, drug development, cancer biology, clinical oncology, clinical trials, and patient care management